NASDAQ:AFIB Acutus Medical (AFIB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC Filings About Acutus Medical Stock (NASDAQ:AFIB) Get Acutus Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume7,037 shsMarket Capitalization$3 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Acutus Medical, Inc. was a medical technology company focused on improving the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. Headquartered in Carlsbad, California, the company developed technologies for cardiac electrophysiology procedures, which use catheters and imaging systems to identify and treat abnormal heart rhythms. Its principal product was the AcQMap 3D Imaging and Mapping System, designed to create detailed, real-time maps of the heart’s electrical activity and anatomy. The system was intended to help physicians locate sources of arrhythmias and guide catheter ablation procedures. Acutus also developed related electrophysiology products, including mapping catheters, access sheaths and other procedural tools. Founded in 2011, Acutus Medical served hospitals and electrophysiology specialists in the United States and select international markets. The company became publicly traded on the Nasdaq under the symbol AFIB in 2020. Its subsequent corporate operations and product ownership changed as the company pursued strategic alternatives, so historical descriptions of Acutus Medical primarily relate to its cardiac mapping and ablation technology business.AI Generated. May Contain Errors. Read More Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFIB Stock News HeadlinesAFIB Acutus Medical, Inc. - Seeking AlphaJuly 1, 2025 | seekingalpha.comEnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology AssetsJuly 1, 2025 | finance.yahoo.comElon gets it. Do you?Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.September 24 at 1:00 AM | Porter & Company (Ad)Acutus Medical Stock Short Interest Report | OTC:AFIB | BenzingaMay 26, 2025 | benzinga.comAcutus Medical Reports Full Year 2024 Financial ResultsMarch 24, 2025 | globenewswire.comAcutus Medical Announces Operational DownsizingDecember 4, 2024 | globenewswire.comAcutus Medical Reports Q3 2024 Financial ResultsNovember 20, 2024 | markets.businessinsider.comStudy reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutterNovember 14, 2024 | msn.comSee More Headlines AFIB Stock Analysis - Frequently Asked Questions How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The business earned $4.60 million during the quarter, compared to analyst estimates of $6.02 million. Acutus Medical had a negative net margin of 272.74% and a negative trailing twelve-month return on equity of 311.64%. Does Acutus Medical have any subsidiaries? The following companies are subsidiaries of Acutus Medical: Acutus Medical N.V.. When did Acutus Medical IPO? Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), PayPal (PYPL) and Rio Tinto (RIO). Company Calendar Last Earnings11/11/2021Today9/24/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AFIB CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees85Year Founded2011Profitability EPS (Trailing Twelve Months)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.66 million Net Margins-272.74% Pretax Margin-30.32% Return on Equity-311.64% Return on Assets-11.57% Debt Debt-to-Equity RatioN/A Current Ratio1.85 Quick Ratio1.57 Sales & Book Value Annual Sales$7.16 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / BookN/AMiscellaneous Outstanding Shares29,912,000Free Float28,228,000Market Cap$3 thousand OptionableNo Data Beta5.73 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:AFIB) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredI went to a party with Elon...Josh Baylin, a former Bloomberg tech reporter and ex-SAC Capital analyst, has spent weeks building a paper tra...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
